Health Canada drug identification number

DIN 02442620 — KALYDECO 75 MG

KALYDECO is a granules of Ivacaftor marketed by VERTEX PHARMACEUTICALS (CANADA) INCORPORATED. The full Ivacaftor monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02442620
Brand name
KALYDECO
Active ingredient
Ivacaftor
Strength
75 MG
Dosage form
GRANULES
Route
ORAL
Manufacturer
VERTEX PHARMACEUTICALS (CANADA) INCORPORATED
Health Canada status
MARKETED
Drug class
CFTR potentiator

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Ivacaftor products

DINBrandStrengthFormManufacturerStatus
02543451 KALYDECO 13.4 MG GRANULES VERTEX PHARMACEUTICALS (CANADA) INCORPORATED MARKETED
02397412 KALYDECO 150 MG TABLET VERTEX PHARMACEUTICALS (CANADA) INCORPORATED MARKETED
02519364 KALYDECO 25 MG GRANULES VERTEX PHARMACEUTICALS (CANADA) INCORPORATED MARKETED
02442612 KALYDECO 50 MG GRANULES VERTEX PHARMACEUTICALS (CANADA) INCORPORATED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.